Doctors Miss This Antidepressant Pitfall

Doctors walking in a hospital corridor reviewing a tablet — Photo: Gorodenkoff / Shutterstock

Millions of Americans take antidepressants every year, but almost nobody in the medical system can tell them how to safely stop.

Quick Take

A 2022 review of 21 major depression guidelines found none gave clear instructions on how to taper antidepressants or manage withdrawal symptoms.
Fifteen of those 21 guidelines admitted withdrawal happens, but most failed to list specific symptoms or how long they might last.
Doctors have no reliable way to tell patients apart who are suffering withdrawal from those relapsing into depression.
New clinics and updated guidelines are starting to fill the gap, but the healthcare system still treats stopping medication as an afterthought.

A System Built To Start Treatment, Not End It

For decades, medicine has focused on getting patients onto the right drug. Far less attention has gone to helping them get off one. A systematic review published in 2022 examined 21 clinical practice guidelines on depression from around the world. It found that most guidelines briefly mention tapering but almost none explain how to actually do it.

Researchers found that 15 of the 21 guidelines, or 71 percent, acknowledged that stopping antidepressants can cause withdrawal symptoms. But fewer than half named even one specific symptom patients might expect. No guideline offered a complete list. That leaves doctors guessing and patients confused when they start feeling sick after their last dose.

This is not a small clinical detail. Antidepressant withdrawal can include nausea, dizziness, insomnia, and mood swings that mimic the very depression the drug was meant to treat. Without a clear symptom checklist, doctors can misread withdrawal as relapse. That mistake can lead a patient right back onto a medication they were trying to leave behind.

Guidelines Say Taper Slowly, But Rarely Say How

Most guidance boils down to one instruction: reduce the dose gradually. Some sources suggest a minimum four-week taper after long-term treatment, with slower schedules stretching over months for people who have taken the drug for years. Others recommend even more caution, suggesting reductions over months or years for higher-risk patients, using liquid formulations to allow smaller, more precise dose cuts.

Scotland’s health system has tried to be more specific, telling clinicians that patients on short courses can taper over a minimum of four weeks, while those with serious side effects may need to stop within seven days or less. Britain’s National Institute for Health and Care Excellence updated its own guidance in 2023, telling doctors to reduce doses in stages to ease withdrawal effects. These are steps forward, but they remain the exception rather than the rule across most national guidelines.

Why The Gap Persists

Part of the problem is money and attention. Drug approval research focuses on proving a medication works, not on studying how to stop it. Few large clinical trials have ever tested different tapering strategies head to head. That leaves doctors relying on expert opinion rather than hard data when they counsel patients on stopping.

The consequences fall hardest on patients and the doctors treating them day to day. When withdrawal guidance is thin, patients bear the discomfort and confusion, while doctors risk misdiagnosing relapse. Guideline committees and hospital systems, meanwhile, face little pressure to fix a problem that shows up quietly, one patient at a time, rather than in a headline-grabbing crisis.

Seven drug regulators, including the EU, UK, and Canada, have warned since 2019 that antidepressant-linked sexual side effects can persist for years after the drug is stopped. The US hasn’t. | Lab Report, ScienceBlog

The European Medicines Agency’s safety committee concluded in… pic.twitter.com/25rV2vizum

— Owen Gregorian (@OwenGregorian) August 26, 2026

Some doctors are pushing back on that neglect. One physician who struggled with his own withdrawal symptoms went on to found a clinic dedicated to helping patients taper off antidepressants safely, and later helped write new tapering guidance for Britain’s Royal College of Psychiatrists. His work, along with a growing handful of specialty clinics, suggests the fix is possible. It just requires the same seriousness that goes into starting a prescription.

What This Means For Patients Right Now

For now, patients considering stopping an antidepressant should expect to ask their doctor pointed questions, since many general guidelines simply will not have the answers. Deprescribing, the deliberate process of reducing or ending a medication when it no longer serves the patient, needs the same rigor as prescribing does. Until healthcare systems build that structure, patients are often left to advocate for their own careful, gradual exit.